PharmaRelations has received Gazelle Awards in Norway, Denmark, Sweden and as a Nordic Group, recognizing the company as a sustainable high-growth business over time.
The company’s most recent award was presented by the Norwegian business newspaper Dagens Næringsliv at the end of 2025, recognizing the strong development of PharmaRelations’ Norwegian subsidiary. In 2024, PharmaRelations Group received the Gazelle Award from Dagens Industri in Sweden, while the Danish subsidiary received its third Gazelle Award from Börsen in 2023.
Earlier, in 2019, PharmaRelations was honored with the prestigious “Master Gazelle” award by Dagens Industri, highlighting the company’s continuous growth journey since receiving its first Gazelle Award in 2007. All in all, PharmaRelations have received 12 GazelleAwards.
“Continuous adaptation to client demands and long-term relationships are the backbone of PharmaRelations’ growth over the decades. They reflect both the way we think and our company culture,” says Åsa Uppströmer, CEO of PharmaRelations.
“The transformation within Life Science is ongoing, just as it is in many other industries. Our role is to understand our clients’ challenges, adapt to their evolving needs, and develop new solutions that help them succeed”
“I am proud that PharmaRelations Norway has received the Dagens Næringsliv´s Gazelle Award 2025. For me and my team, it is a recognition of our quality, customer focus, and ability to create value for our clients,” says Liv Östbye, Country Manager Norway and Finland.
“It also inspires us to continue developing new services and solutions for the market. Sustainable growth is built on consistently meeting customer demands and delivering the services our clients need — again and again.”